Europe

Sessions

Wednesday, 23 October

09:00

e-poster session day 1

09:00 to 18:20

Digital kiosks

e-poster session

10:50

Advances in drug treatment

10:50 to 12:20

Auditorium II

Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

10:50 to 12:20

Auditorium VI

Oral presentation session

Lives at risk: mental health and substance use

10:50 to 12:20

Auditorium VII

Oral presentation session

Prevalence of opioids and related harms

10:50 to 12:20

Auditorium VIII

Oral presentation session

Gambling: work-related, financial, and criminological issues

10:50 to 12:20

Room 5B

Oral presentation session

Building addiction workforce capacity

10:50 to 12:20

Room 5C

Oral presentation session

Support for recovery

10:50 to 12:20

Room 1.07

Short communication session

Closed session

ECR Programme — Scientific writing

10:50 to 12:20

Room 1.10

Workshop

Evaluation of drug consumption rooms: guidance step by step

10:50 to 12:20

Room 1.15

Workshop

13:20

Neuroscience and cognition

13:20 to 14:50

Auditorium III

Short communication session

Legal shifts and their Impact on drug use and sentencing

13:20 to 14:50

Auditorium IV

Oral presentation session

Drug policy and the criminal legal system

13:20 to 14:50

Auditorium VI

Oral presentation session

Gender and substance use

13:20 to 14:50

Auditorium VIII

Oral presentation session

Substance use interventions in youth

13:20 to 14:50

Room 5A

Oral presentation session

Meetings the needs of women who use drugs or alcohol

13:20 to 14:50

Room 1.06

Short communication session

Methods and measurement

13:20 to 14:50

Room 1.08

Short communication session

15:00

Challenges in community-based prevention

15:00 to 16:30

Auditorium I

Major session

The recovery journey

15:00 to 16:30

Auditorium III

Oral presentation session

Infectious diseases in people who inject drugs

15:00 to 16:30

Auditorium IV

Oral presentation session

Measuring drug market phenomenon

15:00 to 16:30

Auditorium VI

Oral presentation session

Substance use and psychosis

15:00 to 16:30

Auditorium VII

Oral presentation session

The growing threat of synthetic drugs – developments and responses in North America and Europe

15:00 to 16:30

Auditorium VIII

Oral presentation session

Surveillance of drug-related morbidity and mortality

15:00 to 16:30

Room 5A

Oral presentation session

Inequalities and needs of migrant groups

15:00 to 16:30

Room 5C

Oral presentation session

Responses to behavioural addictions

15:00 to 16:30

Room 1.05

Short communication session

Problematic gambling and gaming

15:00 to 16:30

Room 1.07

Short communication session

Conceptualising health and harms

15:00 to 16:30

Room 1.08

Short communication session

16:50

NPS: trends, concerns and response strategies

16:50 to 18:20

Auditorium III

Oral presentation session

Drug use trends

16:50 to 18:20

Auditorium IV

Oral presentation session

Understanding interrelationships: mental health and substance use

16:50 to 18:20

Auditorium VII

Oral presentation session

Psychedelics 1

16:50 to 18:20

Auditorium VIII

Oral presentation session

Opioid treatment 1

16:50 to 18:20

Room 5B

Oral presentation session

Motivations for use

16:50 to 18:20

Room 5C

Oral presentation session

Hepatitis C, HIV, and other drug related harms

16:50 to 18:20

Room 1.05

Short communication session

Opioids: trends, use and treatments

16:50 to 18:20

Room 1.06

Short communication session

18:30

Why are we not doing better at reducing drug-related deaths?

18:30 to 19:30

Auditorium I

Big debate

Thursday, 24 October

09:00

Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.

09:00 to 10:30

Room 1.10

Workshop

Workshop on conducting drug research in prison: Challenges and key recommendations from the European experience

09:00 to 10:30

Room 1.15

Workshop

10:50

Opioid treatment 2

10:50 to 12:20

Auditorium III

Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

10:50 to 12:20

Auditorium IV

Oral presentation session

Evidence informed drug and alcohol policy

10:50 to 12:20

Auditorium VI

Oral presentation session

Emerging drug harms, DCRs and other responses

10:50 to 12:20

Auditorium VII

Short communication session

Innovative methods for understanding drug markets and policy

10:50 to 12:20

Room 5A

Oral presentation session

Challenges, threats, and opportunities in addiction publishing today

10:50 to 12:20

Room 1.05

Oral presentation session

EU research funding opportunities

10:50 to 12:20

Room 1.07

Workshop

Contemporary issues

10:50 to 12:20

Room 1.08

Oral presentation session

13:20

Novel neurobiology - cannabis, cognition and craving

13:20 to 14:50

Auditorium III

Oral presentation session

Understanding drug-related deaths

13:20 to 14:50

Auditorium IV

Oral presentation session

Young people, mental health and substance use

13:20 to 14:50

Auditorium VII

Oral presentation session

Pregnancy, drug use and care

13:20 to 14:50

Room 5B

Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

13:20 to 14:50

Room 1.05

Short communication session

European prevention curriculum: increasing the use of evidence-based prevention

13:20 to 14:50

Room 1.06

Short communication session

Women's realities of drug use

13:20 to 14:50

Room 1.08

Oral presentation session

Scenarios for the future of addictions fields by 2040

13:20 to 14:50

Room 1.10

Workshop

Writing for 'addiction' journals for early career researchers with DEPP Editors-in-Chief

13:20 to 14:50

Room 1.15

Workshop

15:00

NPS: Pharmacological Characterization and Substance Analysis

15:00 to 16:30

Auditorium III

Oral presentation session

Cannabis legalisation — models and impacts

15:00 to 16:30

Auditorium VI

Oral presentation session

Protective and risk factors in drug prevention

15:00 to 16:30

Room 5A

Oral presentation session

Policy issues in gambling

15:00 to 16:30

Room 5B

Oral presentation session

City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction

15:00 to 16:30

Room 1.07

Workshop

How to respond to real-time drug alerts in European countries ?

15:00 to 16:30

Room 1.15

Workshop

16:50

Mixed methods for understanding drug use

16:50 to 18:20

Auditorium III

Oral presentation session

Viral hepatitis among people who inject drugs

16:50 to 18:20

Auditorium IV

Oral presentation session

Substance use and mental health in treatment settings

16:50 to 18:20

Auditorium VII

Oral presentation session

Misuse of medicines

16:50 to 18:20

Auditorium VIII

Oral presentation session

From old to new: changes in drug use

16:50 to 18:20

Room 5C

Oral presentation session

Newly regulated markets, managing harms, treatment & advocating for reform

16:50 to 18:20

Room 1.06

Short communication session

Internet, smartphones and social media use

16:50 to 18:20

Room 1.07

Short communication session

Friday, 25 October

09:00

A comparative discussion on the role, challenges, and opportunities for addiction nurses within Europe

09:00 to 10:30

Room 1.15

Workshop

10:50

The ripple effect: International developments in the opioid market and their potential implications for European public health and security

10:50 to 12:20

Auditorium I

Major session

Gaming and social media use

10:50 to 12:20

Auditorium III

Oral presentation session

Intentional and non-intentional drug-related deaths

10:50 to 12:20

Auditorium IV

Oral presentation session

Psychedelics 2

10:50 to 12:20

Auditorium VI

Oral presentation session

Unravelling the nexus: understanding drug-related violence across Europe

10:50 to 12:20

Auditorium VIII

Oral presentation session

Online monitoring

10:50 to 12:20

Room 5B

Oral presentation session

Substance use and treatment needs across European prisons

10:50 to 12:20

Room 5C

Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

10:50 to 12:20

Room 1.05

Short communication session

Gaming and health

10:50 to 12:20

Room 1.06

Short communication session

How can cannabis policy goals inform the development of evaluation indicators?

10:50 to 12:20

Room 1.08

Workshop

13:20

Alcohol and other drug policies in the work setting – a perspective on European developments

13:20 to 14:50

Auditorium II

Oral presentation session

Overdose prevention

13:20 to 14:50

Auditorium IV

Oral presentation session

Addressing diverse treatment needs

13:20 to 14:50

Auditorium VI

Oral presentation session

Substance use and mental health in prison settings

13:20 to 14:50

Auditorium VII

Oral presentation session

Regulating cannabis supply policies in Europe: navigating the long road to change

13:20 to 14:50

Auditorium VIII

Oral presentation session

Prevention and addiction in underrepresented groups

13:20 to 14:50

Room 5A

Oral presentation session

Impact of drug policy on drug production & markets

13:20 to 14:50

Room 5B

Oral presentation session

Future of opioid markets in Europe: Foresight approaches

13:20 to 14:50

Room 1.10

Workshop

Presentations

Wednesday, 23 October

09:00

e-poster

The role of dissociative experiences in the link between psychological distress and Problematic Social Network Sites Use

Effectiveness of the brief intervention for methamphetamine users in Poland

The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis

Is addiction a brain-disease? An overview of the evidence

09:00 to 18:20

Digital kiosks

Chrysanthi Blithikioti

e-poster

Life Entrapment or Trampoline? Understanding life experiences of rejected asylum seekers in Copenhagen’s open drug scene

Tell me who you are, I'll tell you what to do: designing specific interventions for different types of gamers

Portuguese gym-goers versus Performance-enhancing Substances: What do we know?

Offspring of individuals with alcohol use disorders and professionals in addiction counseling: A qualitative study

Anabolic steroid use and use of other image- and performance-enhancing drugs on the rise – A new substance use disorder

An audit of patient’s Health / Social Care needs referred to a Dual Diagnosis Social Care pathway in Ireland

Training Program for Self-management of Substance Addiction Consequences – a Randomized Controlled Trial Pilot Study

Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study

Cannabis use and severity of cannabis dependence among Georgian small-scale cannabis growers in 2021

Empowering higher education teachers using tripartite drug awareness training model to support youth well-being

Exploring the role of gender on treatment outcomes in older adults with alcohol use disorder

Hepatitis C and pharmaceutical multinationals. An approach to the case of Basque Country (Spain) in 2014/2015

09:00 to 18:20

Digital kiosks

Unai Perez de San Roman Landa

e-poster

Exploring Diverse Applications of Multicriteria Decision Analysis in Drug Policy: A Comprehensive Overview.

Exploring Cultural Dynamics of Black Asian Ethnic Women in Addiction Recovery

A digital approach to peer led recovery and social connection to address substance use/and or mental health challenges

Systematic review of recovery of neuropsychological function following abstinence in people with an Alcohol Use Disorder

Evaluation of inpatient conversion from high dose methadone to long-acting injectable buprenorphine (LAIB)

The association between psychological distress and alcohol consumption and physical activity

Workforce development and co production as key enablers of successful service delivery.

Degree of smartphone addiction in the university environment

Personality traits and recovery

09:00 to 18:20

Digital kiosks

Elise Constance Fodstad

e-poster

A narrative review of nurse-led addiction models of care; informing the foundations for international nursing.

09:00 to 18:20

Digital kiosks

Sadie Lavelle Cafferkey

e-poster

Transgender and non-binary people's experiences with alcohol reduction in the UK: A cross-sectional study

Activities and Experiences of Czech Adolescents in Cyberspace

Developing a Toolkit for health care professionals working with Pregnant People who use Drugs in Southern Africa

09:00 to 18:20

Digital kiosks

Julie-Anne Mac Donnell

e-poster

Drug-Facilitated Sexual Assaults involving GHB and GBL in Europe – recent evidence and a need for better monitoring.

Systemic biases: Attitudes of correctional staff toward incarcerated people receiving opioid agonist treatment

The Development of an Alcohol Strategy for the Northwest Territories, Canada

Making Hep C treatment more accessible for addictions patients in Belfast

Harm Reduction: A Pathway To Community Health in Nigeria

09:00 to 18:20

Digital kiosks

Fatima Abiola Popoola

e-poster

A business of supplying harm reduction : a necessary evil?

Association of Alcohol and Tobacco use on COVID-19 outcomes: A Study from East India

09:00 to 18:20

Digital kiosks

e-poster

A systematic review of second-hand smoking mass media campaigns (2002-2022)

Risk of relapse to non-opioids among patients treated with XR-NTX or BP-NLX: A randomized clinical trial

The lived experience of persons receiving harm reduction services, finding an oasis in the deserted life of drug use

Evaluation of participants' experiences enrolled in a community-based mobile withdrawal management service

A feasibility and tolerability study of home-use tDCS in patients with substance use disorders (SUD)

Substance Use Treatment for non-speaker of the native language: Implications for migrants and the displaced

From intrusive memory to craving in cocaine use disorder – An ecological momentary assessment study

Addiction-related dreams: Interpretative Phenomenological Analysis of content and recovery from addiction

Adverse childhood experiences, adult attachment and parenting styles in a population with addictive behaviors

The addiction nursing workforce empowerment - from international perspective to the national implementation and bac

Barriers to Substance Use Treatment as Perceived by Professionals and Arabic Refugees in Germany

Prevalence of substance use in Austrian prison systems

The Moral Improvisation of Harm Reduction in Abstinence Based Drug Policy Amongst Frontline Drug Workers in Hong Kong

COMPARED RETENTION RATES BETWEEN PATIENTS TREATED WITH BUVIDAL IN FRANCE vs. SUBLINGUAL BUPRENORPHINE (OPALE-2 STUDY)

Enhanced Alcohol-Specific Pavlovian-to-Instrumental Transfer in Alcohol Use Disorder

Implementation of a subject on the care of addiction in the Nursing degree: origin of the need and expectations.

09:00 to 18:20

Digital kiosks

Sheimah El Beijjaji Bouzbita

e-poster

Development of complementary information to drug-related deaths statistics in Slovenia

Post-prison support for First Nations men in Australia and Canada

Framing alcohol policies in non-prohibitionist States: An existentialist dilemma?

Cybervictimisation, emotion regulation and family factors in adolescents and young people

09:00 to 18:20

Digital kiosks

e-poster

Resilience and Sense of Coherence as Mediators in the Association between Problematic Mobile Phone Use and Depression

Cannabis use and its link to psychopathological and functional outcomes: Insights from self-reports and hair data

09:00 to 18:20

Digital kiosks

Lydia Johnson-Ferguson

e-poster

People with mental disorders resulting in addiction to alcohol in Poland - legal aspects of medical, social assistance.

09:00 to 18:20

Digital kiosks

Joanna Rajewska de Mezer

e-poster

Integrating Seven Challenges Mastery Counselling and Trauma Informed Care in adolescent substance use interventions.

"Make the difference" - Qualifying professionals working with families with addiction issues

Electronic cigarettes use among secondary school students in Slovenia

Implementation of two transdiagnostic psychological interventions for alcohol use: Study protocol, preliminary results

New criminal legal strategies towards a more effective inmate treatment (The KETHEA PROMITHEAS project)

Balancing between care and control - staff perception on the introduction of new medication for opioid agonist treatment

09:00 to 18:20

Digital kiosks

Andrea Johansson Capusan

e-poster

ADDIRIS - Addiction and Harm Reduction: a global French-speaking network for online learning

Results of İntegrated Bio-Behavioral surveillance among PWID in Azerbaijan

Burnout and Engagement in Addictive Behaviors and Dependencies HCWs at Portuguese North Region: an epidemiological study

Enrichment of Prevention Methodologies with Self Help/Mutual aid practices: The case of the Centre of Prevention Greece

ComunicAr’te - Communicating through Art in Group Therapy on Addictive Behaviors

Twenty years of integrated treatment of dual disorders in the netherlands: lessons learned

Professional satisfaction and discontent: perspectives of health professionals on Addictive Behaviors and Dependencies

Evaluation of a UK Bristol capillary blood service for blood-borne virus detection to reach HCV elimination targets

Prevalence of BBD among PWID in treatment settings in Palestine between 2019-2023

Social work diagnosis and intervention in a harm reduction service for People Who Use Drugs

In search of protective factors against burnout in Addictive Behaviors and Dependencies HCWs at Portuguese North Region

HCV screening in the treatment centers for people with addictions: lessons learned

Combination non-medical use of gabapentin and medications for opioid use disorder: A qualitative study

Online gambling and Loneliness: A State of Knowledge.

09:00 to 18:20

Digital kiosks

Volanirina Rasolofomamonjy

e-poster

A Look at Non-Compliance: Examining Alcohol Industry Marketing Practices in Portugal

Forgotten children - losses of children growing up with addicted parents

The effects of syringe service programs on overdose deaths in Tennessee

The association between alexithymia and binge drinking among young people

Drug checking via Syringe Vending Machines

Alcohol, transitions and communities of belonging within marginalised groups – towards a model of understanding.

The prevalence of Mental Health Disorders Among Cannabis Users

Problematic Mobile Phone Use Related Changes in Topological Organization of Functional Brain Networks

Comorbid bloodborne diseases among people with opioid use disorders on medication-assisted treatment in Tanzania.

Use of CBD and low-THC products in North Macedonia

Pilot implementation of a drug overdose reporting tool among Texas harm reduction organizations: A mixed methods study

Working memory in context: the role of alcohol distractors in low to heavy alcohol drinkers

Contribution of the workforce to retention of clients in Kombani Medically Assisted Therapy (MAT) in Kwale, Kenya.

Hospitalizations due to the use of psychoactive substances in Portugal: Impact assessment of the 2008 economic crisis

Exploring the gendered impact on women of the impact of the changes in commissioning in drug and alcohol services.

Using a digital client segmentation tool among clients with problematic substance use

Chemsex: An Umbrella Review

Mania a Potu: Review of the literature

Challenges and needs of Cologne's open drug scene: insights from a quantitative study on Neumarkt square

Medicinal use of non-prescribed cannabis: motives for use, perceived effectiveness and barriers to treatment (MEDUSA)

Improving the diagnosis and clinical outcomes on drug addict patients through quantitative spectrometer testing.

DCR in Paris : a constant experiment

The Intersection of Gambling with Smoking and Alcohol use in Great Britain: A Cross-Sectional Survey in October 2022

Identification and treatment of alcohol use disorder with the 15-method – implementation in psychiatric care

Benefits of a Yoga intervention in portuguese female inmates: preliminary results

Long-Term Outcomes of Substance Use Treatment: A 20-Year Follow-Up Study in the Swedish Addiction Treatment System

Doping Prevention among Recreational Athletes and the Role of the Police

Mortality Rates and cause-specific mortality in Patients with Substance-Induced Psychosis

Psychological Phenotypes in Glambling Disorder: A case study using the Pathway Model

Trilhos - Evaluation of a developmental prevention program

Developing practical tools for identifying and supporting treatment-relevant cognitive dys/functions

The potential of eHealth in the treatment of substance use disorders: a perspcitive on digital theraies

Scottish stakeholder views on closing the evidence to practice gap in substance use prevention

Impact of Adherence to the Opioid Substitution Program on Social Determinants of Health in the West Zone of Porto

Inpatient ketamine detoxification, characterization of a treatment-seeking population with complex needs

Effects of oxytocin and nicotine addiction on psychosocial stress: an fMRI study

Catalysts for Change: Youth-Driven Insights in Opioid Harm Reduction

"Pictures (and Drugs) at an exibition"

Prevention of FASD in Luxembourg – a status report

The role of COVID-19 in sleep quality and cognitive performance in alcohol–dependent patients

Psychosocial and financial vulnerabilities in loot box purchasing: The mediating role of problem gambling

Psychological factors associated to problematic gambling in university students from Lima, Perú.

09:00 to 18:20

Digital kiosks

e-poster

OUTCAST REGISTRATION: an archive of imprisoned female drug users' biographies

Electroencephalographic indices of stages of reward memory and implications for therapeutic memory reconsolidation

HIV among people who inject drugs in Stockholm - prevalence, incidence and treatment outcomes

A National Survey of Alcohol Care Teams (ACTs) in England: Characteristics of Patients and Components of Care

The role of cartoon humor in the context of addictology efforts for the prevention of alcohol and tobacco use

Exploring dual diagnosis in opioid agonist treatment: A comparative study between the Czech Republic and Norway

The Value of Outreach (VALOR): An evaluation of the implementation of alcohol assertive outreach in Greater Manchester

Crack cocaine use, street life and migrant population. An Italian observatory by ItaRdd, Cnca, Forum Droghe.

Alcohol, Driving and Crime - Health Care and Justice: An Outreach Intervention

Buprenorphine prescription patterns at a tertiary care hospital in northern India: A retrospective chart review

Critical assessment of the role of compulsory treatment of drug use disorders in Germany

Negative affectivity, mania, and defense mechanisms in compulsive online buying-shopping disorder

Gratitude amidst unease: Interviews with Swedish forensic psychiatric male patients with substance use disorder

Mapping drug users’ spaces of fear in Cologne, Germany

Assessing Food Security and Hunger in Heroin-Assisted Treatment (HAT) Participants: Insights from Norway's HAT Project

Reitox National Focal Point Drug Monitoring System as a Model for Monitoring Other Addictions in Czechia

Characterising South Africa’s drug markets with people who sell heroin, methamphetamine and cocaine

Assessing hindering and facilitating factors of help-seeking behaviour in cannabis use: descriptive qualitative study

SCIRe: Substance Consumption Informative Research - testing hair in electronic music festivals

Recreational substance use and cognition in a large cohort of young adults with hair testing: Something is not nothing

Smartphone addiction and sexual distress: preliminary findings of a study in Portugal

Neurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence

Italian teenagers’ perceived exposure to Digital Alcohol Marketing

No alcohol at night – Polish experiences

When substance use disorder and eating disorder intersect: an integrated care tool.

The role of temperamental self-regulation in predicting treatment outcome in alcohol use disorders

Ethical considerations of responsible gambling in metaverse

Alcohol guidelines in Australia - who knows them?

09:00 to 18:20

Digital kiosks

e-poster

Love Addiction: Trait Impulsivity, Emotional Dysregulation and Attachment Style

TREATMENT PROGRAMS FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH MENTAL AND BEHAVIORAL DISORDERS DUE TO PAS USE

Using Functional Near Infrared Spectroscopy to Detect Neurocognitive Differences Across Social Drinking Patterns

Global trends and Challenges of the Drug Phenomenon in Central Asia

Online gambling and betting in India and their adverse psychological and social complications: A comprehensive review

09:00 to 18:20

Digital kiosks

Shyam Sundar Kanagarajan

e-poster

Psychosocial Determinants of Cannabis Protective Behavioral Strategies: Perceived Efficacy and Social Norms

09:00 to 18:20

Digital kiosks

Fermin Fernández Calderón

e-poster

Nightlife recreational contexts in Viseu: sexism, sexual violence and potential associations with substance use

09:00 to 18:20

Digital kiosks

Inês Miguel Rodrigues Armelim

e-poster

Impact of fruit smoothie supplementation on psychological distress in patients undergoing opioid agonist therapy

09:00 to 18:20

Digital kiosks

Elaheh Javadi Arjmand

e-poster

Frequency of cannabis and amphetamine use past month in patients on opioid maintenance treatment with buprenorphine

Generative AI to support Harm Reduction

30 years of New Psychoactive Substances (NPS) in Europe. A first integrated public health assessment.

Comparison of HOMA-IR, Tg/Glucose Index and Tg/HDL-C ratio for predicating MetSy in HCV seronegative heroin dependents

Rhabdomyolysis in patients following opioid overdose

09:00 to 18:20

Digital kiosks

Aleksandra Babulovska

e-poster

Common mental disorders in prisoners with childhood trauma and substance use; the role of emotion regulation

Program evaluation of a team-based approach addressing mental health and addictions in a Canadian urban centre

Public Health addressing illicit drug use and mental health disorders: Interinstitutional Community Intervention Group

Investigating the Relationship Between Stigma and Relapse in IDUs with HIV/AIDS in Pakistan

09:00 to 18:20

Digital kiosks

Jawwad Muhammad Shujaat

e-poster

If you don't know where you're going, why insist on running - A reflection on the lack of data on dropout...

Features and correlates of Internet Gaming Disorder in women and men who play video games: a cross-national study

09:00 to 18:20

Digital kiosks

Caitlin McClure-Thomas

e-poster

Challenges in the management of skin and soft tissue infections among people who inject drugs in Athens, Greece.

Association between slot machine gambling and debt recovery process-Finnish population-based study with register linkage

The recovery of people with addictive behaviours and dependencies: intervention strategies of social workers

Self-inflicted cut throat injuries and substance use during COVID-19: An analysis from Nepal

Role of Psychiatric Nursing Staff in a Newly Founded Ward for Treatment of Adolescents Facing Addiction

Long-term Effects of the STAD-model: A Multi-Component Responsible Beverage Service Intervention

Therapeutic Effects of Ayahuasca: The Psychological Processes Involved in the Relief of Depression and Grief.

09:00 to 18:20

Digital kiosks

Mafalda Pinto Ribeiro

e-poster

Threat or opportunity: End-user perspectives on digital interventions for treatment of cannabis use

Gender violence experienced by women who use drugs

09:00 to 18:20

Digital kiosks

Ana Isabel Ibar-Fañanás

e-poster

Psychosocial Factors Affecting Drug Relapse Among Youth in Pakistan

COVID-19 and earthquakes-related stress, quality of life, mental health, and internet-based addictive behaviour

Process indicators and outcomes of patients with SUD and Emotional Disorders: Comparison of pre-post COVID-19 pandemic

An evaluation of “harm reduction” outreach service evaluative research in Macau

Smoking among people who use drugs

Conceptual competence in addiction: integrative contributions from philosophical and theoretical work in psychiatry

Impact of first cardiovascular event versus consecutive episodes on tobacco and alcohol use: a comprehensive analysis

Navigating cannabis access in zurich: A road safety perspective from early observations of the 'Züri Can' study

The impact of the tobacco law on hospitalizations due to the abusive consumption of psychoactive substances

Anxiety, Depression, Stress, and Self-Harm in relation to Gaming Disorder: A Longitudinal Study of Czech Adolescents

Complicated Alcohol Withdrawal Syndrome: retrospective study of an inpatient alcohol treatment unit

Addiction, a volitional disorder.

Oniomania: a case study according to the differential diagnosis

Advancing Addiction Interventions: Porto's Comprehensive Approach in the Municipal Health Plan

"Supersavers" manages large proportion of opioid overdoses – 5-year follow-up of a regional naloxone program, Sweden

Mapping psychedelic retreats and other practices in the EU

Oniomania: what is known today?

Ageing in the context of the Opioid Maintenance Treatment in Portugal: Impact of public health policies on ageing users

Recreational Cannabis and Social Media Use: A Correlational Cross-Sectional Study

Psilocin inhibits CYP450 metabolism of isoforms 2A6 and 3A4

09:00 to 18:20

Digital kiosks

Andreia Machado Brito-da-Costa

e-poster

"How generational transmissions can shape life?" Evaluation of a genogram group therapy for people with ACoA syndrome

Piloting a strategy to prevent and manage alcohol-related problems in underage population at risk in health services

09:00 to 18:20

Digital kiosks

Carla Filipa Bruguera

e-poster

Burden of disease due to drug use disorders in the European Union: analysis of 1990-2019 trends and patterns

Willingness and Contextual Considerations for Supervised Consumption Sites among People Who Inject Drugs in Stockholm

LGBTQIA2S+ perspectives on problem gambling among their peers: Preliminary results of semi-structured interviews

DUDIT-E Brazilian Adaptation and TrIE-AD Application Development: A Intervention Approach for Young Drug Users

09:00 to 18:20

Digital kiosks

Richard Alecsander Reichert

e-poster

Riscos & Desafios Program: the students’ voice

THE ROLE OF WORK IN THE TREATMENT OF INDIVIDUALS RECOVERING FROM ADDICTION

Changes in self-reported alcohol use post absolute alcohol sales bans: the case of Botswana during COVID pandemic.

Understanding Overdose Risk Perception in People who use Drugs - A Systematic Review

Effects of a universal school based alcohol prevention intervention

Risky online behavior in relation to social support, depression and anxiety in Czech adolescents

Veterinary Drugs as Toxic Adulterating Substances in the Street Drug Supply

IN VITRO INHIBITORY POTENTIAL OF CLASSIC HALLUCINOGENS LSD, 5-MEO-DMT AND MESCALINE OVER CYTOCHROME P450 ENZYMES

Working Towards Health and Wellness: The Infinite Pathways of Recovery

Can we prevent the misuse of prescription stimulants? : a case report

09:00 to 18:20

Digital kiosks

Ivana Todorić Laidlaw

e-poster

Risks and challenges of scaling up the intervention – an analysis of the program dissemination process

Lived/Living experiences: the potential for integrative collaborations

Applying foresight research for drug policy: Lessons from the DRUG-PREP project

Estimation of prevalence (and patterns) of cannabis use from various data sources

Providing psychiatric services for hepatitis C virus patients with substance use disorders

Acute and Chronic Effects of Cannabis on the Neural Correlates of Working Memory in Adolescents versus Adults

The future of smoking is female: Barriers for women to quit. A review.

09:00 to 18:20

Digital kiosks

e-poster

High and repeated use of MDPV induce chronic psychosis in patients with no psychiatric history

A Prospective Study: Patterns and Trends in Opioid Use and Treatment with Focus on Older Populations

Suicidal Behaviors and Alcohol Dependence: A Comprehensive Literature Review

Assessing progress towards viral hepatitis B and C elimination in prison settings in the European region

Experiences with Xylazine among Residential Treatment Patients

The role of coping in the association between cannabis use disorder and mental health; a one-year prospective study

Analysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon

Community led networking and advocacy for the elimination of discrimination of women who use drugs in Europe

Experiences of female substance users with trauma-sensitive yoga as complementary support in addiction treatment

Efficacy of a digital intervention to reduce or stop cannabis use : study protocol for a randomized controlled trial

Self-rated health among patients in opioid agonist therapy

Sleep dysregulation in alcohol use disorders. An exploratory study with a gender perspective.

Voices of the unhoused from Santa Fe, New Mexico: health status, substance use, and community harm reduction views

The Last Decade in Turkish Addiction Research: A Thesis-Based Analysis

Fentanyl among adolescent in Poland - the scale of the phenomenon and preventive actions

09:00 to 18:20

Digital kiosks

Ewelina Silecka-Marek

e-poster

The comparison and analysis of blood antioxidant levels in alcohol and drug addiction

Stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes

Cortical thickness and brain aging in individuals engaging in unhealthy alcohol use

Alcohol use across trials of psychological interventions for bipolar: A systematic review and meta-analysis

Optimizing Overdose Response in the Emergency Department: New challenges and initiatives in Scotland

Hybrid skills transfer of the unplugged prevention programme in a French high school abroad (Lisbon, Portugal 2023 2024)

Applied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers

Caring with Care: VITAE’s integrative and therapeutic model towards socially vulnerable individuals

09:00 to 18:20

Digital kiosks

Brenda Sousa da Silva

e-poster

Addictive Behaviours Workforce development: from global to European higher education programs

09:00 to 18:20

Digital kiosks

Olatz López Fernández

e-poster

Substance Use Among College Students in India: Necessity for Intervention

Meaning and Self-control in Alcohol Use and Internalizing Symptoms: Causal Insights from (Non)clinical Populations

Italian Validation of Assessment of Recovery Capital Scale in Clinical Population with Alcohol and Drugs Use Disorder

Building Capacity for Social Return on Investment Analysis of Supervised Consumption Services in Saskatoon SK, Canada

Intervention methods for the psychological problems faced by the wives of individuals with substance use disorders.

09:00 to 18:20

Digital kiosks

Ranasinghe Mudiyanselage Sanjeewani Senevirathne

e-poster

Systematic analysis of Interventions for Opioid Use Disorder Among Adolescents

Perceptions of alcohol-related problems among social workers and their clients

09:00 to 18:20

Digital kiosks

e-poster

The prevalence, risk and protective factors of the co-morbidity of neurodiversity and substance use.

SCHEMATIC FUNCTIONING AND EMOTIONAL REGULATION IN ALCOHOL DEPENDENCE: A CLINICAL AND NON-CLINICAL SAMPLE COMPARISON

09:00 to 18:20

Digital kiosks

Ana Catarina Nunes da Silva

e-poster

Unmasking addictions: exploring the role of attributional styles

Prevention Matters: Towards a National Model of Prevention (within the National Programme on Illicit Drugs 2023 - 2030)

Assessing Therapeutic Alliance: A Pilot Study Measuring Therapeutic Alliance and It's Impact on Patient Outcomes

The Impact of psychotherapy on Comorbid Borderline Personality Disorder and Substance Use Disorder: A Systematic Review

09:00 to 18:20

Digital kiosks

Manuel Jesús Ruiz Muñoz

e-poster

The Autonomic Craving Signature: a biomarker of craving for personalized addiction treatment

Enhancing HIV Self-Testing Uptake through Syringe Vending Machines: A Case Study in Tbilisi, Georgia

Therapy of alcohol-dependent women serving prison sentences in Polish prisons

Image and performance enhancing drugs among gym and fitness visitors in Slovenia – preliminary results

09:00 to 18:20

Digital kiosks

Julijana Zucchiati Godina

e-poster

Assessing the prevalence of problem gambling among the Slovenian population

Investigating the relationship between defense styles and treatment motivation of Turkish males with alcohol use problem

09:00 to 18:20

Digital kiosks

Fatmatüz Zehra Pehlivan

e-poster

Packaging of disposable vaping products and e-liquids in England, Canada, and the United States: a content analysis

The effect of smoking cessation interventions on socioeconomic inequalities in smoking: A Cochrane systematic review

Drug-Related Deaths following Bariatric surgery: Case Series Report

Adherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine

Case Series: Prospective Study on the Efficacy of Pregabalin in Managing Opioid Withdrawal Syndrome

Is Integrating Online Stop Smoking Support to Existing Online Talking Therapy Support Feasible?

Is Decriminalising drugs enough? Navigating alternatives to prohibitionism

Leveraging AI to supercharge the training and support of extended workforce in addiction services

Shaping a model for Incentivised Drug Free Living wings in prison

09:00 to 18:20

Digital kiosks

e-poster

Trust in healthcare providers for information about cannabis

Stigma and substance use disorders: a scoping review of patient and health care professionals’ attitudes.

The necessary adaptation of a public Therapeutic Community to new needs of the treatment process.

Cannabis use and withdrawal and escalation to psychiatric intensive care

“To smoke feels gender”: A Photovoice Study of Cannabis Use Among Transgender and Non-Binary Youth

The effect of Cue-induced Retrieval and Reconsolidation with Episodic Foresight on craving in opioid users receiving MMT

Cannabis legalization in Germany: Update on an ongoing process

09:00 to 18:20

Digital kiosks

e-poster

Spanish version of the Bergen Social Media Addiction Scale (BSMAS): validity, reliability and measurement invariance

Impact of the Decriminalization on Drug Use Experiences and Related Risks among People Who Use Drugs in British Columbia

Opiate-Dependent Service Users knowledge and attitudes towards Supervised Injecting Facilities

10:50

NIDA International Program Research Update

Lisdexamfetamine in the treatment of methamphetamine dependence, a randomised controlled trial

Understanding the research capacity of Australian alcohol and other drug services

Managing Benzodiazepine Dependence and High-Risk Use with Opiates: A feasibility study of a Co-produced Intervention

Treatment of benzodiazepine withdrawal through taper dosing is most successful when it lasts less than 6 months.

World Addiction Medicine Reports: International Society of Addiction Medicine Global Expert Network Global Surveys

10:50 to 12:20

Auditorium VI

Oral presentation

Report from LX24 side event - Strengthening networks and sharing innovation in practices on research and surveillance in the drugs field

10:50 to 12:20

Auditorium VI

Vickna Kasinather, Charles Parry

Oral presentation

The effectiveness of naloxone in reversing opioid overdose: The European naloxone outcome research study (NalPORS)

Scaling up Harm Reduction: Results of the 3-year Take-Home Naloxone project NALtrain in Germany.

Foundations of Prevention Science and Practice Curriculum: Providing Technical Assistance through Training

10:50 to 12:20

Room 5C

Maria Paula Luna Jimenez

Oral presentation

The reciprocal effects of gambling expenditure and crime.

Enhanced self-efficacy in HCV management: educating a multidisciplinary drug and alcohol workforce in Europe and Canada

Gambling Disorder and Work Disability: A National Registry Study in Sweden

Addiction and financial burden: Longitudinal 6-time point analysis of risk factors for debt enforcement in Finland

Problem Gambling Among Criminal Sanction Clients: Project Overview

Bipolar disorder and severe poisoning due to medicines or illicit substances

The impact of severe mental illness on treatment retention and all-cause mortality of people in opioid agonist treatment

Hazardous substance use and mental health among refugees in shared accommodations – a mixed-methods study

Suicide-related service presentations following residential treatment for substance use disorders: a data linkage study

EUDA research model

Non-invasive brain stimulation restores METH-induced behavior disorder via prefrontal cortex-ventral striatum circuit

10:50 to 12:20

Auditorium II

Oral presentation

Modelling the wider socio-economic costs of problematic opioid use in the UK

Twenty-one years of heroin-related mortality in Australia: Joinpoint regression analysis of trends by age and gender

Underestimate of deaths due to specific opioids in England and Wales for a decade

Prevalence of opioid dependence in Scotland, 2015-2020: results from a Multi Parameter Estimation of Prevalence model

A systematic review of the nuances of attachment, bonding and parenting for mothers in addiction recovery

The role of specialist substance use and addiction treatment in building recovery capital

Recovery does not stop at discharge: A qualitative evaluation of Alcohol Recovery Navigators in North East England.

Exploring Personal Strengths and Resources in Long-Term Substance Use Disorder Recovery: Insights from Lived Experience

The effect of Individual Placement and Support on employment outcomes for individuals with substance use disorders

Understanding the process of drug addiction recovery through learning from lived experience

Emotional dysregulation as a predictor of cocaine severity and withdrawal symptoms

Exploring Australian addiction workers' views on inclusive treatment for transgender and gender diverse (TGD) clients.

10:50 to 12:20

Room 5C

Nic Robinson-Griffith

Short communication

Embodied Storytelling: An Accessible Approach to Re-storying in the Recovery Process

13:20

Why is a gender perspective needed in the drug field? Insight from the latest European drugs data.

Cultural adaptations in adolescent prevention programs: a scoping review on substance use and mental health.

13:20 to 14:50

Room 5A

Oral presentation

Developing and operationalising a multi-component drug outreach service for young people aged 16-25 in England

Bridging the Gap: Exploring School Survey Data in Drug Policy and Prevention - Insights from the ESPAD-MedSPAD Project

Risk factors for the gambling, smoking and alcohol consumption triad: an observational study in Portuguese adolescents

Navigating the Shift: Understanding the Dynamics of Cannabis Use in Germany Amidst Legalization Prospects

Policy and Practice Responses to Drug-Related Deaths: Governance issues in English and Welsh Prisons, 2015-2021

MATPACT: An innovative approach to finding Scotland’s forgotten generation

Global coverage of interventions to prevent and manage injecting drug use related harms in prisons: a systematic review

Drug-induced homicide laws in the US: current trends, stakeholder opinions, and public health impacts

The perspective of transgender and non-binary people on their substance use trajectories and resilience processes

Attention and reward related brain activity in cannabis users: A registered report of a longitudinal study

Neural Correlates of Addiction: A Resting-State Meta-Analysis of Substance Use Disorders and Behavioral Addictions

The bodily parallel: Bridging Gaps in Current Theories of Addiction and Interoception

13:20 to 14:50

Auditorium III

Mateo Leganes-Fonteneau

Short communication

Social Cognition in people with substance use disorders

Does lisdexamfetamine maintenance help or hinder cognitive function in people with current methamphetamine dependence?

Smoking and nicotine use behaviours among women of reproductive age: a ten-year population study in England

NK1 antagonism modulates negative emotional processing in abstinent opioid dependent individuals and healthy controls

Gender Compression Over Time in Measures of Cannabis Use by Age and Cohort in the United States

Easy to reach, hard to research: cognitive function and substance use characteristics of people with severe drug use.

Phosphatidylethanol as a screening tool for alcohol consumption during pregnancy

Decoding the Darknet: A Deep Dive into Hidden Drug Markets and Health Impacts

13:20 to 14:50

Auditorium IV

Short communication

Digital Invisibility: Presence of Substance Use Disorder Treatment Programs for Women in the Caribbean

The effects of legislative measures for 3-MMC in the Netherlands on drug sample composition and self-reported effects.

Utilization of pharmacological treatment for alcohol use disorder in pregnancy in the total Swedish population

Leximetric analysis of drug laws and evaluation of outcomes: cross-country analyses approach

The important role of social connectedness in the alcohol use of women aged 50 to 62 years.

Judge Demographics and Their Impact on Sentencing of Drug Crimes

Barriers and Enablers in Disclosing Substance Use by Pregnant Women in Australian prisons

Tuning In for Chemistry: Setting up a multi-instrument mobile drug-checking lab at a 7-day psychedelic music festival

In favor or against the codependency concept: A narrative review of arguments in scientific literature

13:20 to 14:50

Room 1.08

Alexis Beaulieu-Thibodeau

Short communication

The relationship between cannabis and tobacco use - a systematic review and meta-analysis

Towards 2029: Learnings from unified Australian involvement in drug-related United Nations fora

13:20 to 14:50

Room 1.08

Short communication

Prevalence and trends of ethanol and drugs among arrested drivers in Norway in the period 2013-2023

Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders

Risk and protective factors in adolescents: adapting Communities that Care Youth Survey for Portuguese context

Alcohol prevention: a review using Topic Modelling

Cannabis and mental health in Germany: a baseline estimation pre legalization

Evaluation of heroin-assisted treatment in Norway: Protocol for a mixed methods study

13:20 to 14:50

Room 1.08

Lars Henrik Myklebust

15:00

Oral presentation

Increased hepatitis C and HIV incidence among people who inject drugs in Montreal, Canada, 2011-2023

What do we (not) know about community-based prevention and how to move forward?

Canada synthetic opioids situation

Evidence-based prevention through collaborative action? Opportunities and challenges for community-based participatory research in prevention science

Emerging drug trends – what are the issues and how can we strengthen preparedness

Challenges in community-based prevention

US experience with synthetic drugs

The key components of CTC, including forming intersectoral coalitions, using a data-driven and needs-oriented approach to select evidence-based measures, and considering local contextual conditions during implementation.

15:00 to 16:30

Auditorium I

Maximilian von Heyden

Oral presentation

The U.S. international perspective including the Global Coalition

“They kicked me out of hospital twice”: barriers and facilitators accessing care with an injecting-related infection

15:00 to 16:30

Auditorium IV

Samantha Colledge-Frisby

Oral presentation

HIV Risk behaviors of People who Inject drugs in 12 districts of Bangladesh: Evidence from a Rapid Situation Assessment

15:00 to 16:30

Auditorium IV

Oral presentation

Decentralized consultation for infectious diseases with at-risk populations: preliminary results

Associations of alcohol consumption with long-term mortality of ART-naïve persons seeking HIV care. 

Mothers receiving substance use treatment involved in care proceedings: A record linkage cohort study

Mortality among first-time opioid agonist therapy patients in Austria, 2002-2021: A national retrospective cohort study

Drug poisoning deaths of under 30-year-olds – Key issues in the cause of death investigation documents

Acute drug-toxicity presentations involving crack cocaine to Euro-DEN Plus sentinel hospitals in Europe from 2014-2022

The long and winding road to gambling disorder treatment

Drug markets and financial flows: underground banking in the Netherlands

How do purity and price of cocaine affect consumption in Austria?

Outcomes from the first womens’ residential treatment centre for gambling harm in the UK

15:00 to 16:30

Room 1.05

Oral presentation

Documenting major shifts in methamphetamine and heroin prices and purity in metropolitan and rural Victoria, Australia

A pilot program using Tabletop Role-Playing Games to reduce social anxiety and addiction symptoms in online gamers

Effects of recreational cannabis versus black market: A randomized controlled trial in Switzerland (WEED CARE)

Efficacy assessment of the universal problem-gambling prevention program "What at stake?"

Toward a classification of technology design features promoting potentially addictive online behaviors

The “Me and others” prevention program: impact evaluation in a sample of Portuguese adolescents

A mindfulness-based intervention for craving reduction in gambling and video gaming disorder: A case study.

15:00 to 16:30

Room 1.05

Francisco José Rivero Ramón

Oral presentation

Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis

Antipsychotics and relapse risk in persons with first-episode psychosis and co-occurring cannabis use disorder

“Into a whirlwind”: Navigating psychosis and anti-psychotic treatment among youth entrenched in an urban drug scene

Cannabinoid Use Experience among inpatients with psychotic symptoms – A Cross-Sectional study in a Portuguese Hospital

15:00 to 16:30

Auditorium VII

Carolina Afonso Romano

Oral presentation

Migrants in the criminal justice system: A qualitative understanding of the role of substance use in their lives

"Boxing Clever Cork saved my life": an evaluation of an Irish early addiction recovery initiative

Drug use and (non-)use of addiction treatment by women in French Guyana: gender and migration effects

A Safer Downtown for All: Including People Who Use Drugs in the Solutions to Social Disorder

Police stops for drugs: Exploring the use of stop and search for drug offences in England

15:00 to 16:30

Room 5C

Oral presentation

Superiority and cost-effectiveness of Individual Placement and Support for people with alcohol and drug dependence

Challenges and support needs among persons with a migration background who use drugs in four metropolitan cities

15:00 to 16:30

Room 5C

Wouter Vanderplasschen

Oral presentation

Building Capacity For Future Evaluation of Residential Treatment for People Experiencing Homelessness and Addiction

Envisioning youth-dedicated overdose prevention and drug consumption sites in Canada and Portugal

Exploring the biopsychosocial needs of ageing heroin users in treatment in Malta: implications for service provision

What increases the risk of problem gambling in adolescents? Findings from the Greek arm of the ESPAD study

Financial hardship and gambling severity: a population-based study in Finland

Late relapse among ex-smokers using e-cigarettes following a quit attempt: a prospective one-year follow-up study

Extended hours of video game play and negative physical symptoms and pain

Substance induced psychosis among persons with concurrent mental health and substance use disorders under pandemic

Prevention is key: A case of a gambling prevention program among Portuguese high-school students

15:00 to 16:30

Room 1.07

Short communication

Religiosity and gambling - moderating role of reflective thinking: A Polish-Georgian Study

Associations between mental health and substance use in higher education students in Germany – a cross-sectional study

Suicide by people in contact with drug and alcohol services: a national study 2021 to 2022

Chronic pain and suicide-related behaviours in people engaging with Alcohol and Other Drug services.

15:00 to 16:30

Room 1.08

Short communication

Harmful types of gambling: Changes and emerging trends in longitudinal helpline data

Mental health in people with hazardous cannabis and alcohol use - insights from a study of regulated cannabis sales

Accessibility, local socioeconomic disadvantage and expenditure on electronic gambling machines

Psychoactive Substance Use Among Russian Migrants Relocated to Georgia Following the 2022 Ukrainian Invasion

The influence of CBT based treatment and therapeutical contract guidelines on a problem gambler abstinence treatment

Online Gambling Companies’ Interpretation of Duty of Care and its Implication for Responsibilisation of Gambling Related Harm

Refugees & drug use in Belgium: A national study on drug-related intervention needs in the reception setting (DrugInt)

Barriers and facilitators for accessing HCV care in PWID: a qualitative study using an intersectional approach

16:50

What are the reasons for injecting methadone? A qualitative study among people who inject drugs in Barcelona

Monitoring intravenous drugs use in Spain through syringe residue analysis

16:50 to 18:20

Auditorium IV

Carlos Pernas-Fraguela

Oral presentation

Codeine, oxycodone, and tramadol prescription prior to overdose deaths compared to toxicological findings

STTBI risk reduction with OAT among people with prescription-type opioid use disorder

Are Australian pharmacists willing and prepared to offer Hepatitis C services? Findings from a representative sample

Looking under rocks: Skin infections in people who use drugs: a mixed-methods investigation in Wales

HCV antibody and RNA testing combined with nursing and peer-based outreach to enhance HCV testing and treatment among vulnerable groups

16:50 to 18:20

Room 1.05

Solange Mendes Ascensão

Short communication

Prevalence and microelimination of Hepatitic C in intravenous drug users - improving linkage to care

Improving the model of care pathway for HCV between the drug care centres and their referral hospitals in Catalonia.

16:50 to 18:20

Room 1.05

Elena Torrell -Pedreira

Oral presentation

20-year trends in Australian methamphetamine-related deaths: An age–period–cohort–interaction analysis

The relationship between self-reported childhood maltreatment and mental health in substance use disorders

16:50 to 18:20

Auditorium VII

Aleksander Hagen Erga

Oral presentation

Effects of cannabis use timing and formulation on sleep among young adults who report high-intensity alcohol use

Examining Associations Between Alcohol and Cannabis Simultaneous and Concurrent Co-Use and Mental Health Outcomes

Synthetic cathinones in drug-related deaths – an alarming issue or triviality?

Trends in GHB use and harms in Australia

Emergence of semi-synthetic cannabinoids in Europe – a perspective from the European Union Early Warning System

A Collaborative Approach to New Drug Identification in an Emerging Drug Early Warning System

Achieving universal health coverage of opioid agonist treatment in Norway: a cost-utility analysis

Route-Dependent Subjective Effects of Medical Heroin in HAT: Implications for Treatment Trajectories

AN IMPLEMENTATION SCIENCE EVALUATION OF SCOTLAND’S FIRST HEROIN ASSISTED TREATMENT (HAT) FACILITY

Reduced health care utilization after entering opioid agonist treatment; change in mental and somatic health domains

‘Russian Roulette’: how do people who co-use benzodiazepines and opioids experience the absence of harm reduction?

Motivations for cocaine use: relation with drug use patterns, risks and how this informs prevention

Heavy drinking among ‘sober generation’ youth: a longitudinal study

Motivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study

Trends in the detection and co-detection of drugs in a population attending opioid agonist treatment: 2010 to 2020

Being Seen and Heard: Exploring the Relational Dimension of Heroin Assisted Treatment in Norway.

Death after residential treatment for opioid use disorder among people using fentanyl

The U.S. Psilocybin Landscape: Policy Evolution and Nationally Representative Insights

Self-therapeutic use of psilocybin, MDMA and ketamine among Dutch nightlife attendees.

Medical use of psychedelic substances: EUDA's monitoring of key developments

Navigating Psychedelic Therapy for Addiction: Past, Present, and Future

16:50 to 18:20

Auditorium VIII

Short communication

Oxycodone and Morphine use in hospitals and primary healthcare in Norway 2010-2021

Global utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder

Mortality among long-term prescription opioid users

Adão e Eva II Project – HIV, Hepatitis and other STI’s prevention and screening among hard-to-reach populations

Comorbidity of substance use disorders and other mental health disorders: towards a common European approach

18:30

Why are we not doing better at reducing drug-related deaths?

18:30 to 19:30

Auditorium I

Thomas Clausen, Marie Jauffret-Roustide, Keith Humphreys, Paul Dietze, Katri Abel-Ollo

Thursday, 24 October

10:50

Oral presentation

Long-acting injectable buprenorphine for opioid use disorder: key findings from a longitudinal qualitative study

Associations between opioid agonist therapy exposure and chronic pain characteristics among people who inject drugs

Adapting Opioid Therapy: Transition from Methadone to Slow-Release Morphine Amid COVID-19 Supply Chain Disruptions

Reasons for (non-)using a drug consumption room: the point of view of drug users.

Safe Inhalation Pipe Provision Study: Intervening to improve policy and practice for people who use crack in England.

A scoping review of mass media interventions intended to reduce stigma towards people who use drugs

Overdoses in the drug consumption room in Oslo: route of administration matters!

Changes in the use of non-prescribed hydromorphone and unregulated opioids use in Vancouver, Canada, 2018-2022

Definition of public amenity in drug consumption room literature: A scoping review

Enhancing Harm Reduction: A Qualitative Evaluation of Athens' Drug Consumption Room

The Value of Peer Research: A Peer Perspective

Cannabis policy and practice in Finland: from social media discussions to citizens initiatives

Perceptions of family physicians in Istanbul on e-cigarettes as smoking cessation aids

Key challenges for alcohol epidemiology and alcohol control policy evaluation

Legally grey? Drug checking perspectives in the CEECA region

Public health for whom? Unpacking the assumptions and silences in Canada's public health approach to substance use.

Opioid disorder treatment outcomes — the OPTIMUS international consensus on evidence-based and patient-centred care

The Costs and Harms of Substance Use in Canada: Key Trends from 2007 to 2022

Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022

Health-related quality of life trajectories of patients in heroin-assisted treatment

Examining declining opioid agonist treatment rates during pregnancy in Ontario, Canada

10:50 to 12:20

Auditorium III

Oral presentation

European Hair Drug Analisys Network – A pioneer study to investigate the use of NPS and NSO

A Global Perspective on Treatment Service Provision for Opioid Use Disorders

10:50 to 12:20

Auditorium III

Arash Khojasteh Zonoozi

Oral presentation

Synthesis of multisource data for the development of an advanced dashboard to monitor illicit drugs markets

A Holistic Multi-Disciplinary Healthcare Pathway for Older Men who use Anabolic Androgenic Steroids

Drugs and climate change: knowledge gaps in monitoring environmental impacts of drugs

Impact of long-acting depot buprenorphine post-release from custody– Early findings from the Release Study

A wastewater-based approach to monitor shifting trends in illicit drugs consumption in Switzerland

What can Portugal do to prevent be caught off guard again in the drug domain?

Challenges, threats, and opportunities in addiction publishing today

10:50 to 12:20

Room 1.05

John Marsden, Matilda Hellman, Anees Bahji, Bryon Adinoff

Oral presentation

Did the relaxation in supervised opioid agonist treatment during Covid-19 increase methadone-related deaths in England?

13:20

Empowering Global Drug Prevention: A Systematic Approach

Making a case for health promotion theoretically underpinned policies and practices around alcohol in workplace settings

Introducing the European Prevention Curriculum (EUPC) in Austria – findings from a pilot implementation

Advancing Science-Based Prevention: Insights from the EUPC Training in Bosnia and Herzegovina

Piloting EUPC Training in the Republic of Georgia: Lessons Learned

13:20 to 14:50

Room 1.06

Jana D. Javakhishvili

Short communication

TRAINING ON THE EUROPEAN PREVENTION CURRICULUM (EUPC) FOR DOPs- THE CYPRIOT EXPERIENCE

The Frontine Politeia project: the need for involving prevention implementers within substance use and crime prevention

Dynamic associations between anxiety and alcohol use from early adolescence to young adulthood.

Strengthening the capacity and agency of drug prevention stakeholders on the key issue of evidence-based prevention.

Prescribed safer supply in British Columbia: de-prescribing and impacts on substance use

13:20 to 14:50

Room 1.05

Short communication

A multisite implementation trial of collaborative care for Opioid Dependence: 3-month outcomes from the EPIC-MATOD trial

A socio-ecological systematic review of harm reduction interventions addressing the U.S. opioid overdose epidemic

Treatment pathways and transitions of young adults during opioid maintenance treatment

Drug-related deaths among housed and homeless individuals in the UK and the USA

Effect of integrated smoking cessation treatment on smoking intensity among persons who receive opioid agonist treatment

13:20 to 14:50

Room 1.05

Karl Trygve Druckrey-Fiskaaen

Oral presentation

Drug-related mortality associated with gabapentinoid/Z-drug co-prescribing among opioid-agonist treatment recipients

Experience of marginalized PWID with harm reduction interventions in the context of primary healthcare.

13:20 to 14:50

Room 1.05

Oral presentation

Policy Responses to Drug-Related Deaths: The power of numbers?

Homeless people and mental health: an observational study in an Emergency Shelter in Lisbon

High body mass index is prevalent in people with opioid use disorder in Northern England and increases risk of death

An economic evaluation of Catalonia’s Needle Exchange Programme (NEP). Cost-Benefit analysis

13:20 to 14:50

Room 1.05

Asier Narbarte Arzuaga

Oral presentation

A randomized controlled trial of support programs for parents of treatment-refusing substance using young adults

Understanding substance use and affective symptoms in late adolescents in an urban context: A network approach

Contextualising experiences of comorbid mental ill-health and substance use among trans and gender diverse young people

13:20 to 14:50

Auditorium VII

Oral presentation

Cannabis use disorder and the brain: The role of cross-cultural differences in cannabis attitudes

Substance use variation among LGBTQ+ youth: stress, resilience and ecosystemic intervention

13:20 to 14:50

Auditorium VII

Julie-Christine Cotton

Oral presentation

Peripheral endocannabinoids and related lipids in individuals with chronic non-medical prescription opioid use

The genetic etiology of cannabis use: from twin models to genome-wide association studies and beyond

Vulnerabilities and agencies of women who use and sell drugs in Bordeaux and Montréal

Executive functioning and addictions: an epidemiological point of view

13:20 to 14:50

Auditorium III

Oral presentation

Unveiling the Nexus of Addiction, Violence, and Risk: Generational Patterns in Female Populations

Differential effects of left and right insula inhibition on craving and cognitive control in regular smokers

Female-specific trends and treatment needs for substance use disorder among homeless and at-risk females

Gender and drugs: Experiences of stigma/toxicophobia and narcofeminist narratives

13:20 to 14:50

Room 1.08

Marie Jauffret-Roustide

Oral presentation

A mixed methods systematic review of interventions for women in the perinatal period, who are dependent on drugs

The care pathways of women who use drugs in the perinatal period. Findings of a qualitative, longitudinal study

Pregnancy-related hospitalisation among women who inject drugs in Melbourne, Australia

"Conscious Loss": the decision of women with cannabis use disorder to stop smoking cannabis during pregnancy

13:20 to 14:50

Room 5B

Short communication

Multi Parameter Estimation of Prevalence modelling: methods to estimate the prevalence of opioid dependence in Scotland

13:20 to 14:50

Room 1.05

Andreas Markoulidakis

Foresight workshop on developing scenarios

The perinatal period as a window of opportunity for change and recovery? A study of mothers and relatives' accounts

15:00

Factors associated with cocaine use in late adolescence and young adulthood in the Growing Up in Ireland cohort study

Who is driving under the influence of cannabis in Germany? Findings of a large-scale online survey

Adverse childhood experiences and drug use in early adulthood: an analysis of the Growing Up in Ireland 1998 cohort

Biography, age and temporality: understanding shifts in alcohol consumption over time among young abstainers

Prevention when exclusion is lifted: Intervention models from the New Swiss Gambling Act

Online Addictions Expert Group of the Pompidou Group: Results and Recommendations

The end of responsible gambling

A provisional evaluation of Australia’s medical cannabis framework

Consequences of cannabis legalization on use and health outcomes on the basis of international experiences

A comparative analysis of state-controlled models for legal cannabis sales in Uruguay and Quebec (Canada)

Same Intentions, Different Outcomes: Divergent Paths and Implementation Gaps in Cannabis Legalization in North America

Brorphine analogues as new psychoactive substances: in vitro and in vivo pharmacological characterization

In vitro cannabinoid activity-based screening of seized plant materials: a future-proof harm reduction strategy?

Neurotoxicity of synthetic cathinones: Can metabolism play a role?

Pharmacology of 30 semisynthetic cannabinoids – and why details matter when assessing the harm potential of seized drugs

Risks and harms associated with online gaming and gambling

16:50

Epidemiology of injecting drug use and injection related harms among people who are incarcerated

Exploring exposure to drug-related content on social media among youth and a pilot of drug prevention on TikTok

Towards elimination of hepatitis C in Oslo: cross-sectional prevalence studies in 2018, 2021, 2022 and 2023

Context specific factors that impact on the optimal scale up of hepatitis C testing and treatment in the UK

The development of a toolkit to support the elimination of viral hepatitis B and C in prisons

Happy, healthy smartphone use: A participatory action research to improve higher education students’ mental well-being

Presentation of a National Observatory for Internet and Gaming Addiction in Greece

Is attentional absorption a risk factor for smartphone addiction?

Procrastination and Problematic Social Network Sites Use in adolescents: a serial mediation model

Loneliness in the Digital Age:Role of Loneliness in Online Self-Verification and Social Media Addiction in Six Countries

Profiles of problematic pornography use and moral incongruence using latent profile analysis: a two-sample study

16:50 to 18:20

Room 1.07

Short communication

Risk factors for the social networking sites addiction: a systematic review

Designing an online training course for professionals dealing with pornography use and sexual dysfunctions

The experience of aging among patients in opioid assisted treatment. A qualitative study.

16:50 to 18:20

Room 1.06

Siv-Elin Leirvåg Carlsen

Short communication

A comparison of sales regulations across three types of cannabis dispensaries: First insights from the 'Züri Can' study

Cannabis users and strain expectancies: A contextual investigation of cannabis strain availability in illicit markets

16:50 to 18:20

Room 1.06

Short communication

Managing the drug-driver: insights from Victoria’s large-scale roadside testing program

Metabolite profile of synthetic cannabinoids seized in Portugal

Diversion to treatment of drug related offenders at the sentencing stage. A quantitative & qualitative analysis

Dual diagnosis and their care pathways for help-seeking: a multi-center study from India

Intervention development of a nature-based programme for co-occurring mental health and substance use problems.

Impact of mental health on retention in OAT

Islands in the stream: The accessibility of mental health care for persons with substance use problems in Belgium

Misuse of psychoactive medicines and its harmful consequences in Portugal

Socioeconomic risk factors for long-term prescription opioid use: A national registry-linkage study

Long-term opioid use following severe traumatic injury as seen from the views of patients and prescribing physicians

16:50 to 18:20

Auditorium VIII

Oral presentation

Using intensive longitudinal data to investigate predictors of cannabis and opioid use among patients with chronic pain

It is time to take nitrous oxide seriously

Nangs in Australia: Investigating nitrous oxide use among people who regularly use MDMA and/or other illicit stimulants

Population aging and apparent decline in initiation of injecting drug use in Australia

Cocaine use on the rise – are politicians and city level services prepared for the emerging trend of crack cocaine?

16:50 to 18:20

Auditorium III

Else Kristin Utne Berg

Oral presentation

Words vs. strands: Does the concordance of self-reported and hair-analyzed substance use of young adults change over time?

Understanding Drug Use in a Dutch Prison: A Call for Improved Research and Care and Lessons learned

New challenges for outpatient care: trends from twenty years of monitoring treatment demand in the city of Hamburg

The impact of Cannabis market Regulation on adolescents in Uruguay

Recommendations from the government cannabis committee on the legal availability of vaping products.

Responding to the identification of nitazenes within the illicit diazepam market

16:50 to 18:20

Auditorium III

Josie Smith

Friday, 25 October

10:50

Oral presentation

Revisiting Goldstein: A New Framework for Understanding Drug-Related Violence in a Globalised Era

Situation in Afghanistan: Opium cultivation and heroin production

An exploration of drug market, gun violence and sociodemographic patterns in Stockholm Sweden and the prediction of gun violence

Opium and heroin production in Southeast Asia

Implications of heroin shortages in Europe: the emergence of synthetic opioids

Homicides committed by criminal groups involved in Swedish drug distribution

The evolving situation with nitazenes in Ireland